+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Cyclovirobuxine D

BP0442
860-79-7
98%
Biopurify
Cyclovirobuxine D(CVB-D) has vasorelaxant effect, it has been widely used for treatment of cardiac insufficiency and arrhythmias in China, the antiarrhythmic and proarrhythmic potential of this drug might be concerned with prolongation of action potential duration and QT interval. CVB-D can induce autophagy in the MCF-7 human breast cancer cell line by attenuating the phosphorylation of Akt and mTOR , CVB-D-induced autophagy and decrease in cell viability could be blocked by 3-methyladenine, a well-established autophagy inhibitor.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0442-20mg 20mg
BP0442-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

AKT1 CASP3 KCNH2 KCNQ1 CACNA1C BAX MTOR
KCNH2 KCNQ1 SCN5A CACNA1C KCNE1
BCL2 PIK3CA AKT1 CASP3 SOD2 SCN5A CACNA1C BAX

Cyclovirobuxine D Related Products

Product drug property prediction parameters

  • 44.2900

  • 4.9954

  • 1.6413

  • .1336

  • 2.4350

  • 6.9708

  • High

  • 65.8029

  • 5.7568

  • No

  • No

  • Yes

  • No

  • No

  • No

  • 0.0

  • No

  • No

  • Yes

  • No

Cyclovirobuxine D Reference LiteratureMORE+